The Food and Drug Administration (FDA) has conditionally approved the antiviral drug remdesivir to treat people with severe COVID-19, the Central Epidemic Command Center (CECC) said yesterday.
At the CECC’s daily news conference in Taipei, Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that no new cases have been confirmed, while 421 people have been released from isolation after contracting the novel coronavirus.
“Taiwan remains the same — with no new domestic cases reported in 48 consecutive days,” Chen said. “However, the COVID-19 situation globally is still serious and almost 6 million cases have been confirmed, so we have to be extra careful about border controls.”
Photo: CNA
After a specialist meeting on Friday, the FDA approved remdesivir to treat people with severe COVID-19, Chen said.
FDA Director-General Wu Shou-mei (吳秀梅) said that to respond to the pandemic, Taiwan needs to prepare treatments, so the administration reached out to pharmaceutical companies.
Gilead Sciences Inc, which produces the experimental antiviral drug under the brand name Veklury, on Monday submitted documents to have the drug approved, and the FDA and the Center for Drug Evaluation immediately launched a review, Wu said.
Photo: CNA
The review was completed by Thursday and with the meeting on Friday, the agencies decided that based on Article 48 of the Pharmaceutical Affairs Act (藥事法), conditional approval would be granted to import Veklury, she said.
The drug can be used to treat severe cases in adults and children, with treatment limited to a maximum of 10 days, she said.
Gilead must enforce a risk management plan and the results of new clinical trials must be immediately sent to the FDA for review, while technical data must be collated within a year, Wu said.
Adult patients are to have 200mg of the drug injected on the first day and receive a 100mg injection once per day from the second day, while children are to be given the same doses if they weigh at least 40kg, she said, adding that dosages would be adjusted according to body weight for children who weigh less than 40kg.
“As many clinical trials are still ongoing, it [remdesivir] is so far one of the most promising drugs we have observed, but the drug approval was granted quickly in response to the emergency need in Taiwan,” Wu said.
The US Food and Drug Administration on May 1 gave the drug emergency use authorization for people hospitalized with severe COVID-19, while Japan on May 7 was the first nation to grant it regulatory approval.
Taiwan is the second nation in the world to have approved the drug.
CECC advisory specialist panel convener Chang Shan-chwen (張上淳) said that although evidence might not yet be sufficient, information on the drug’s effects has been positive, so most specialists support importing the drug to prepare the health system for the possibility of another outbreak.
The drug would only be administered with the informed consent of the patient, and their kidney and liver functions would be monitored to check for adverse reactions, Chang said.
Remdesivir was developed to treat Ebola, but clinical trials showed that it was not effective enough, Wu said.
However, it improved symptoms in severe COVID-19 cases in clinical trials, in which 11 Taiwanese participated, she said.
After the conditional approval is officially granted next week, the FDA plans to order 1,000 doses, which are expected to arrive in Taiwan by late July at the earliest, she said.
Taiwan’s Lee Chia-hao (李佳豪) on Sunday won a silver medal at the All England Open Badminton Championships in Birmingham, England, a career best. Lee, 25, took silver in the final of the men’s singles against world No. 1 Shi Yuqi (石宇奇) of China, who won 21-17, 21-19 in a tough match that lasted 51 minutes. After the match, the Taiwanese player, who ranks No. 22 in the world, said it felt unreal to be challenging an opponent of Shi’s caliber. “I had to be in peak form, and constantly switch my rhythm and tactics in order to score points effectively,” he said. Lee got
EMBRACING TAIWAN: US lawmakers have introduced an act aiming to replace the use of ‘Chinese Taipei’ with ‘Taiwan’ across all Washington’s federal agencies A group of US House of Representatives lawmakers has introduced legislation to replace the term “Chinese Taipei” with “Taiwan” across all federal agencies. US Representative Byron Donalds announced the introduction of the “America supports Taiwan act,” which would mandate federal agencies adopt “Taiwan” in place of “Chinese Taipei,” a news release on his page on the US House of Representatives’ Web site said. US representatives Mike Collins, Barry Moore and Tom Tiffany are cosponsors of the legislation, US political newspaper The Hill reported yesterday. “The legislation is a push to normalize the position of Taiwan as an autonomous country, although the official US
CHANGE OF TONE: G7 foreign ministers dropped past reassurances that there is no change in the position of the G7 members on Taiwan, including ‘one China’ policies G7 foreign ministers on Friday took a tough stance on China, stepping up their language on Taiwan and omitting some conciliatory references from past statements, including to “one China” policies. A statement by ministers meeting in Canada mirrored last month’s Japan-US statement in condemning “coercion” toward Taiwan. Compared with a G7 foreign ministers’ statement in November last year, the statement added members’ concerns over China’s nuclear buildup, although it omitted references to their concerns about Beijing’s human rights abuses in Xinjiang, Tibet and Hong Kong. Also missing were references stressing the desire for “constructive and stable relations with China” and
The Ministry of Foreign Affairs yesterday said it has lodged a protest with Pretoria after the name of the Taipei Liaison Office in South Africa was changed to the “Taipei Commercial Office” on the South African Department of International Relations and Cooperation’s (DIRCO) Web site. In October last year, the South African government asked Taiwan to relocate the Taipei Liaison Office, the nation’s de facto embassy, out of Pretoria. It later agreed to continue negotiating through official channels, but in January asked that the office be relocated by the end of this month. As of the middle of last month, DIRCO’s Web
RSS